• Eastman Chemical Company (NYSE: EMN) was recently removed from both the Russell 1000 Value-Defensive Index and the Russell 1000 Defensive Index, a shift that may alter how certain benchmark-tracking funds gain exposure to the stock.
• This index removal comes as Eastman continues to emphasize molecular recycling growth, a 16-year dividend increase track record, and disciplined capital spending to support its balance sheet.
• Next, we’ll examine how Eastman’s removal from key Russell 1000 defensive indexes may influence its investment narrative and perceived resilience.

AI is about to change healthcare. These 40 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

Eastman Chemical Investment Narrative Recap

To own Eastman Chemical, you need to believe in its shift toward higher value specialty materials and molecular recycling while the company manages cyclical demand and debt. The recent removal from Russell 1000 defensive indexes may affect how some passive funds hold the stock, but it does not fundamentally change the near term catalyst around recycling-driven earnings contribution or the key risk of demand softness and underutilized assets.

The most relevant recent development is the progress at Eastman’s Kingsport methanolysis facility, which added US$60 million in incremental earnings in 2025 with another US$30 million targeted for 2026. This facility sits at the center of Eastman’s recycling growth narrative and directly ties into whether the company can offset weaker volumes and margin pressure in more traditional segments with higher value, sustainability focused revenue streams.

However, investors should also be aware that elevated net debt and a dividend not fully covered by earnings could become more problematic if...

Eastman Chemical's narrative projects $9.6 billion revenue and $870.3 million earnings by 2029. This requires 3.5% yearly revenue growth and about a $471 million earnings increase from $399.0 million today.

Uncover how Eastman Chemical's forecasts yield a $84.33 fair value, a 19% upside to its current price.

Exploring Other Perspectives

While consensus focuses on moderate growth and index removal risk, the most optimistic analysts were modeling earnings reaching about US$980 million by 2029, illustrating how far views can diverge on Kingsport’s potential and highlighting why you may want to compare several scenarios before deciding what this latest index news means for you.

Explore 6 other fair value estimates on Eastman Chemical - why the stock might be worth 8% less than the current price!

Decide For Yourself

Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

• A great starting point for your Eastman Chemical research is our analysis highlighting 3 key rewards and 3 important warning signs that could impact your investment decision.
• Our free Eastman Chemical research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Eastman Chemical's overall financial health at a glance.

Want Some Alternatives?

Don't miss your shot at the next 10-bagger. Our latest stock picks just dropped:

• Uncover the next big thing with 21 elite penny stocks that balance risk and reward.
• Capitalize on the AI infrastructure supercycle with our selection of the 51 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.
• Invest in the nuclear renaissance through our list of 89 elite nuclear energy infrastructure plays powering the global AI revolution.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.